ATE536874T1 - Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen - Google Patents
Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzenInfo
- Publication number
- ATE536874T1 ATE536874T1 AT03724899T AT03724899T ATE536874T1 AT E536874 T1 ATE536874 T1 AT E536874T1 AT 03724899 T AT03724899 T AT 03724899T AT 03724899 T AT03724899 T AT 03724899T AT E536874 T1 ATE536874 T1 AT E536874T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- inhibitors
- chronic pain
- reuppost
- triple monoamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200200832 | 2002-05-30 | ||
| PCT/DK2003/000352 WO2003101453A1 (en) | 2002-05-30 | 2003-05-27 | Triple monoamine reuptake inhibitors for the treatment of chronic pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE536874T1 true ATE536874T1 (de) | 2011-12-15 |
Family
ID=29594978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03724899T ATE536874T1 (de) | 2002-05-30 | 2003-05-27 | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7459464B2 (de) |
| EP (1) | EP1513529B1 (de) |
| JP (1) | JP2005531594A (de) |
| CN (2) | CN101444509A (de) |
| AT (1) | ATE536874T1 (de) |
| AU (1) | AU2003227520B9 (de) |
| CA (1) | CA2484482C (de) |
| DK (1) | DK1513529T3 (de) |
| MX (1) | MXPA04011859A (de) |
| NZ (1) | NZ536415A (de) |
| WO (1) | WO2003101453A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2377987C2 (ru) * | 2003-11-18 | 2010-01-10 | Бёрингер Ингельхайм Интернациональ Гмбх | Твердая лекарственная форма |
| CN101495184A (zh) | 2005-07-15 | 2009-07-29 | Amr科技公司 | 芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用 |
| EP1779851A1 (de) * | 2005-10-31 | 2007-05-02 | Boehringer Ingelheim Pharma GmbH & Co.KG | Behandlung von Diabetes |
| GB0703998D0 (en) * | 2007-03-01 | 2007-04-11 | Glaxo Group Ltd | Novel salt |
| JP5764553B2 (ja) | 2009-05-12 | 2015-08-19 | アルバニー モレキュラー リサーチ， インコーポレイテッド | ７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンおよびその使用 |
| JP5739415B2 (ja) | 2009-05-12 | 2015-06-24 | ブリストル−マイヤーズ スクウィブ カンパニー | （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用 |
| WO2012024397A2 (en) | 2010-08-17 | 2012-02-23 | Albany Molecular Research, Inc. | 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5936675A (ja) | 1982-07-13 | 1984-02-28 | サンド・アクチエンゲゼルシヤフト | 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド |
| WO1994026274A1 (en) * | 1993-05-18 | 1994-11-24 | Wake Forest University | Treatment process with biologically active tropane derivatives |
| SG99853A1 (en) * | 1996-02-22 | 2003-11-27 | Neurosearch As | Tropane-derivatives, their preparation and use |
| GB9617990D0 (en) * | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
| US6331571B1 (en) * | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
| US6323242B1 (en) | 1998-12-02 | 2001-11-27 | Peter Sterling Mueller | Treatment of disorders secondary to organic impairments |
| US6803387B1 (en) * | 1999-03-19 | 2004-10-12 | Abbott Gmbh & Co. Kg | Treatment of neuropathic pain or fibromyalgia |
| DE60026704T2 (de) * | 1999-07-01 | 2006-10-19 | Pharmacia & Upjohn Co. Llc, Kalamazoo | (S,S)-Reboxetine zur Behandlung chronischer Schmerzen |
| JP2005508872A (ja) * | 2001-05-23 | 2005-04-07 | ニューロサーチ、アクティーゼルスカブ | トロパン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害剤として使用する方法 |
| WO2002094827A1 (en) * | 2001-05-23 | 2002-11-28 | Neurosearch A/S | Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
-
2003
- 2003-05-27 AT AT03724899T patent/ATE536874T1/de active
- 2003-05-27 AU AU2003227520A patent/AU2003227520B9/en not_active Ceased
- 2003-05-27 JP JP2004508810A patent/JP2005531594A/ja active Pending
- 2003-05-27 CN CNA2008101763724A patent/CN101444509A/zh active Pending
- 2003-05-27 US US10/515,275 patent/US7459464B2/en not_active Expired - Fee Related
- 2003-05-27 CA CA2484482A patent/CA2484482C/en not_active Expired - Fee Related
- 2003-05-27 EP EP03724899A patent/EP1513529B1/de not_active Expired - Lifetime
- 2003-05-27 NZ NZ536415A patent/NZ536415A/en not_active IP Right Cessation
- 2003-05-27 WO PCT/DK2003/000352 patent/WO2003101453A1/en active Application Filing
- 2003-05-27 MX MXPA04011859A patent/MXPA04011859A/es active IP Right Grant
- 2003-05-27 DK DK03724899.4T patent/DK1513529T3/da active
- 2003-05-27 CN CNA038123762A patent/CN1655787A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1655787A (zh) | 2005-08-17 |
| EP1513529B1 (de) | 2011-12-14 |
| AU2003227520A1 (en) | 2003-12-19 |
| DK1513529T3 (da) | 2012-03-26 |
| WO2003101453A1 (en) | 2003-12-11 |
| US7459464B2 (en) | 2008-12-02 |
| MXPA04011859A (es) | 2005-03-31 |
| CA2484482C (en) | 2011-07-26 |
| NZ536415A (en) | 2006-10-27 |
| JP2005531594A (ja) | 2005-10-20 |
| US20050239824A1 (en) | 2005-10-27 |
| CA2484482A1 (en) | 2003-12-11 |
| AU2003227520B9 (en) | 2008-06-26 |
| EP1513529A1 (de) | 2005-03-16 |
| AU2003227520B2 (en) | 2008-05-01 |
| CN101444509A (zh) | 2009-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063064L (no) | Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte | |
| EA200601553A1 (ru) | Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды | |
| ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| EP1534074A4 (de) | Kombinationstherapie zur behandlung von fettleibigkeit | |
| MY151032A (en) | Treatment of tnf? related disorders | |
| DK1809280T3 (da) | Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf | |
| EA200601239A1 (ru) | Замещённые хинолиновые соединения | |
| HUP0300117A2 (hu) | Interleukin-6 antagonisták alkalmazása aromatáz magas szintjével jellemzett betegségek kezelésére | |
| HRP20050041B1 (hr) | UPOTREBA INHIBITORA IκB KINAZE U TERAPIJI BOLOVA | |
| DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| NO20055741L (no) | Nye kjemiske forbindelser | |
| ATE443044T1 (de) | Tace inhibitoren | |
| SE0302304D0 (sv) | Novel compounds | |
| ATE497809T1 (de) | Myricitrin verbindungen zur behandlung von schlafstörungen | |
| MY136367A (en) | Treatment of cognitive failure | |
| ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
| NO20061425L (no) | Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin | |
| NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
| HUP0204551A2 (hu) | Eljárás a pikkelysömör kezelésére | |
| DE602004019541D1 (de) | Cycloalkyläbü kondensierte indole | |
| DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser | |
| ATE392212T1 (de) | Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen | |
| ATE453386T1 (de) | Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten | |
| UA87117C2 (ru) | Применение пептидных соединений для лечения центральной невропатической боли | |
| DE50308460D1 (de) | Verwendung von ambroxol zur behandlung von chronischen schmerzen |